報價延遲最少15分鐘:2026/02/11 18:10 EST
盤後時段
|
||||
|
2.12 
|
|
|
常規時段 (已結束)
|
|
|
|
|
||||||||||||
|
|
|
|
|
2.12
|
|
|
| 價值評估 |
|
盈利(現時/預測)
0.79/0.39
|
|
企業價值
171.89M
|
| 資產負債 |
|
每股賬面淨值
-2.37
|
| 現金流量 |
|
現金流量率
0.49
|
| 損益表 |
|
收益
197.19M
|
|
每股收益
5.88
|
|
同行比較
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
同行比較之報價最少15分鐘延遲 (夜盤時段除外)
|
業務概覽
|
|||
| Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company derives revenue from United States and also has its presence in other countries. |
